Institute Of Hiv Research And Innovation Foundation, Thailand

This study tests a support service designed specifically for transgender women, men, and non-binary people in Thailand who have used chemsex drugs or other substances in the past year. The program offers HIV prevention (PrEP), mental health support, and STI care. Researchers will…

This study tests a mobile health program designed to reduce HIV-related stigma and improve use of PrEP (a daily pill that prevents HIV) among young transgender women in Thailand. The program includes counseling and stigma-reduction activities delivered via smartphone. Researchers…

This study tests whether adding a tool called the Pleasuremeter to standard harm reduction services helps men who have sex with men and transgender people who use drugs or engage in chemsex talk about and improve their sexual pleasure. The goal is to see if people are willing to …

This study interviews 50 transgender adults in Thailand about their chemsex behaviors—reasons, patterns, and impacts—along with stigma and HIV prevention needs. Researchers also gather input from stakeholders to identify barriers and facilitators for creating transgender-friendly…

This study is gathering information from men who have sex with men who take part in chemsex (using drugs before or during sex) in Bangkok, Thailand. Researchers will survey party hosts and guests about their drug use, sexual health, mental health, and experiences of stigma. The g…

This study follows 150 young men who have sex with men (ages 16-35) who currently use chemsex (drugs before or during sex). Researchers will track physical, mental, and social harms over 6 months, including HIV and other infections. The goal is to learn how to better support thes…

This 20-year study will collect information from up to 300,000 people who visit HIV and sexual health clinics in Thailand. Researchers aim to understand behaviors, social factors, and health needs to improve services. No new treatments are tested; the focus is on gathering data t…

This study looks at whether long-acting antiretroviral drugs for HIV prevention (PrEP) are effective and affordable for key populations in Thailand, including men who have sex with men and transgender women. Researchers will survey over 10,000 people about their preferences, anal…